Efficacy and Safety of Topical Clascoterone Cream, 1%, for Treatment in Patients With Facial Acne: Two Phase 3 Randomized Clinical Trials

IMPORTANCE: Acne is a common, multifactorial skin condition, and treatments with novel mechanisms have been elusive. OBJECTIVE: To assess the safety and efficacy of clascoterone cream, 1%, a novel topical androgen receptor inhibitor, in 2 phase 3 randomized clinical trials (CB-03-01/25 and CB-03-01/...

Descripción completa

Detalles Bibliográficos
Autores principales: Hebert, Adelaide, Thiboutot, Diane, Stein Gold, Linda, Cartwright, Martina, Gerloni, Mara, Fragasso, Enrico, Mazzetti, Alessandro
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Medical Association 2020
Materias:
Original Investigation
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7177662/
https://www.ncbi.nlm.nih.gov/pubmed/32320027
http://dx.doi.org/10.1001/jamadermatol.2020.0465

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7177662/
https://www.ncbi.nlm.nih.gov/pubmed/32320027
http://dx.doi.org/10.1001/jamadermatol.2020.0465

Ejemplares similares